Dysphagia Management Market

SEATTLE, UNITED STATES, UNITED STATES, February 7, 2022 /EINPresswire.com/ -- New Research Study "Dysphagia Management Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights.

Dysphagia occur more commonly in patients suffering from stroke and thus condition is also be a result of autonomic nervous systems. Conditions such as oral, esophageal or oropharyngeal cancer can also lead to dysphagia.

Statistics:

The global dysphagia management market is estimated to account for US$ 5,040.7 Mn in terms of value by the end of 2028.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.coherentmarketinsights.com/insight/request-sample/3612

Market Drivers:

Rise in prevalence of throat cancer is expected to boost growth of the global dysphagia management market over the forecast period. According to the National Cancer Institute, the U.S. recorded around 12,410 new cases of laryngeal cancer and the estimated number of deaths due to the disease was 3,760 in the country.

Market Opportunities:

Additional resources, funding, administrative support, training, and inter-professional communication is required for advancements in dysphagia management. In emerging economies, the physician-patient ratio is low. For instance, according to World Health Organization’s data updated in April 2019, in India, there is one government doctor for every 10,189 people or a deficit of 600,000 doctors, and the nurse: patient ratio is 1:483. Thus, the number of qualified healthcare personnel to detect, assess, and treat persons with symptoms of dysphagia must be increased.

Market Restraints:

Concerns associated with screening, evaluation, and treatment for dysphagia are projected to hinder growth of the market. Screening and bedside evaluation methods, although important initial step in dysphagia diagnostics, are incapable alone of offering detailed assessment of swallowing anatomy. Moreover, there is lack of a universal protocol with both high specificity and sensitivity for predicting aspiration.

Key Takeaways:

The Nutritional Solutions segment in the global dysphagia management market was valued at US$ 1,671.9 Mn in 2021 and is expected to reach US$ 2,758.5 Mn by 2028 at a CAGR of 7.3% during the forecast period. Rising prevalence of throat cancer is projected to propel the growth of the segment during the forecast period.

The Oropharangeal Dysphagia segment held dominant position in the global dysphagia management market in 2019, accounting for 80.6% share in terms of value. The growth of the segment is attributed to growing number of people addicted to smoking during the forecast period.

Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/3612

Market Trends:

High prevalence of dysphagia among U.S. population is expected to accelerate growth of the market. For instance, according to the study, ‘Prevalence and Characteristics of Dysphagia Based on a Population-Based Survey,’ accepted by the journal Clinical Gastroenterology and Hepatology in October 2019, dysphagia affects 16.1% of adults in the U.S. at some point during their lives.

In Europe, several patients do not have adequate treatment for dysphagia. For instance, according to a research conducted by St. Joan Despí & Hospital General of Hospitalet, Spain, in October 2019, 75.4% of patients suffering from oropharyngeal dysphagia did not have adequate complete adapted treatment that included diet and thickener.

Competitive Landscape:

Key players operating in the global dysphagia management market include, Eisai Co. Ltd., C. R. Bard, Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd., Nestlé Health Science, Kent Precision Foods Group, Inc., Bracco Diagnostics Inc., Phagenesis Ltd., Nutricia Advanced Medical Nutrition, and Cook Medical Inc.

Key Developments:

August 2019: Bracco Diagnostics Inc. received the U.S. FDA approval for Varibar Thin Liquid (barium sulfate) for oral suspension used to detect and assess the type and severity of dysphagia

August 2019: Allakos Inc. announced positive results from its Phase 2 randomized, double-blind, placebo-controlled trial of AK002 in patients with eosinophilic gastritis and/or eosinophilic gastroenteritis. AK002 decreased esophageal eosinophil counts and dysphagia symptoms in patients with comorbid eosinophilic esophagitis.

Reasons to Buy this Recombinant Protein Market Report

➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Dysphagia Management market

➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Dysphagia Management market

➡Leading company profiles reveal details of key Dysphagia Management market players emerging five operations and financial performance

➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Dysphagia Management market with five year historical forecasts

➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/3612

The following are the study objectives for this report:

· SWOT Analysis focuses on worldwide main manufacturers to define, assess, and analyse market competition. By kind, application, and region, the market is defined, described, and forecasted.
· Examine the global and main regional market potential and advantage, opportunity and challenge, constraints and risks.
· Determine whether trends and factors are driving or limiting market growth.
· By identifying high-growth categories, stakeholders would be able to analyse market potential.
· Conduct a strategic study of each submarket's growth trends and market contribution.
· Expansions, agreements, new product launches, and acquisitions in the market are all examples of competitive developments.
· To create a strategic profile of the main players and analyse their growth plans in depth.

Check out more studies related to preservatives, published by Coherent Market Insights

Proton Pump Inhibitors Market, by Type (Omeprazole, Pantaprazole, Rabeprazole, Dexlansoprazole, lansoprazole, and Others), by Disease Indication (Ulcers, Gastroesophageal Reflux Disease, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Mr.Shah
Coherent Market Insights
+1 2067016702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.